AQR Capital Management
SYRS

AQR Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

AQR Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$93K Buy
2022
Q1 		$22K Buy
2021
Q2 		– Sell
2021
Q1 		$147K Sell
2020
Q4 		$292K Sell
2020
Q3 		$410K Buy
2020
Q2 		$417K Buy
2020
Q1 		$87K Buy